WINTON GROUP Ltd Acquires New Shares in GE HealthCare Technologies Inc. $GEHC

Posted by Brenda Bartman on Sep 10th, 2026

WINTON GROUP Ltd purchased a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 178,600 shares of the company’s stock, valued at approximately $11,432,000.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. California State Teachers Retirement System grew its position in GE HealthCare Technologies by 5,693.1% during the 2nd quarter. California State Teachers Retirement System now owns 40,913,912 shares of the company’s stock worth $2,618,900,000 after acquiring an additional 40,207,660 shares during the last quarter. Auto Owners Insurance Co increased its stake in shares of GE HealthCare Technologies by 9,525.4% in the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after buying an additional 33,629,559 shares during the period. Norges Bank bought a new position in GE HealthCare Technologies in the 4th quarter valued at approximately $596,024,000. Barrow Hanley Mewhinney & Strauss LLC bought a new position in shares of GE HealthCare Technologies during the fourth quarter valued at $533,655,000. Finally, Cynosure Group LLC raised its position in GE HealthCare Technologies by 21,045.4% during the 4th quarter. Cynosure Group LLC now owns 4,365,462 shares of the company’s stock worth $358,055,000 after purchasing an additional 4,344,817 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $65.17 on Thursday. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.92. The firm has a fifty day simple moving average of $68.43 and a two-hundred day simple moving average of $68.60. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77. The firm has a market capitalization of $29.44 billion, a PE ratio of 14.95, a price-to-earnings-growth ratio of 1.76 and a beta of 0.70.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.09. The firm had revenue of $5.29 billion for the quarter, compared to analyst estimates of $5.26 billion. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period last year, the firm earned $1.06 earnings per share. Analysts forecast that GE HealthCare Technologies Inc. will post 4.93 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Friday, July 24th were given a $0.035 dividend. The ex-dividend date of this dividend was Friday, July 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.21%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the stock. The Goldman Sachs Group restated a “neutral” rating on shares of GE HealthCare Technologies in a research report on Monday, June 8th. Wells Fargo & Company increased their target price on shares of GE HealthCare Technologies from $75.00 to $85.00 and gave the stock an “overweight” rating in a research note on Thursday, July 30th. BMO Capital Markets began coverage on shares of GE HealthCare Technologies in a report on Wednesday, July 8th. They issued a “market perform” rating and a $70.00 price target for the company. Evercore reaffirmed an “outperform” rating and issued a $84.00 price target on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. Finally, Piper Sandler reiterated a “buy” rating on shares of GE HealthCare Technologies in a report on Wednesday, July 29th. Ten analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $77.73.

Read Our Latest Research Report on GE HealthCare Technologies

GE HealthCare Technologies Profile

(Free Report)

GE HealthCare Technologies Inc is a global medical technology, pharmaceutical diagnostics and digital solutions company headquartered in Chicago, Illinois. The company provides products and services designed to support healthcare providers across diagnostic imaging, clinical care and treatment planning.

Its portfolio includes imaging systems such as magnetic resonance imaging, computed tomography, molecular imaging, X-ray and surgical imaging equipment. GE HealthCare also offers ultrasound systems, patient monitoring and care solutions, anesthesia delivery and respiratory care products, maternal and infant care technologies, and healthcare information technology.

The company’s Pharmaceutical Diagnostics business develops and supplies contrast media and radiopharmaceuticals used to enhance medical imaging and support the detection and monitoring of disease.